School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Viatris Inc VTRS

Healthcare · Drug Manufacturers - Specialty & Generic

$17.64last close 2026-10-09 · market cap $20.26B · delayed data

Trailing returns

1M+6.91%
3M+8.77%
6M+31.54%
1Y+82.84%
5Y+59.71%

Basis: Adjusted daily closes.

What it does

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars.

Open VTRS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies